Back to Results
First PageMeta Content
Organic chemistry / Biology / Epoxides / Phosphonic acids / Fosfomycin / Piperazines / Nitrofurantoin / Beta-lactamase / Norfloxacin / Antibiotics / Microbiology / Medicine


Rationale for the EUCAST clinical breakpoints
Add to Reading List

Document Date: 2013-02-18 09:41:04

Open Document

File Size: 184,43 KB

Share Result on Facebook

Continent

Europe / /

MedicalCondition

uncomplicated urinary tract infections / spp Proteus mirabilis Proteus spp Providencia spp Pseudomonas / Enterobacteriaceae Pseudomonas / breakpoints Pseudomonas / Infection / infections / /

Organization

European Society for Clinical Microbiology and Infectious Diseases / Infectious Diseases / European Committee on Antimicrobial Susceptibility Testing / European Centre for Disease Prevention and Control / European Society for Clinical Microbiology / /

Person

DIN NWGA SRGA / DIN NWGA SRGA CLSI / /

Position

E. coli UTI General / /

Product

cephalexin / trimethoprim / ofloxacin / norfloxacin / nitrofurantoin / /

Technology

Alpha / Pharmacokinetics / Pharmacodynamics / 3g / /

URL

http /

SocialTag